Research Options:
Week of Expected Pricing Pending
Company Name Aldagen, Inc
Proposed Ticker ALDH
CUSIP 01408L109
Business Description A biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs.
Lead Underwriter N/A
Co-Managers Cowen and Company, LLC, Wells Fargo Securities, LLC
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.